Cooley M&A

JANUARY 23, 2024

For example, in the biopharma space, AbbVie, Bristol Myers Squibb, AstraZeneca, and Roche each announced multiple big-ticket acquisitions in the fourth quarter – including Abbvie’s acquisition of ImmunoGen for $10.1 billion; Bristol Myer Squibb’s acquisition of RayzeBio for $4.1 billion and Cerevel Therapeutics for $8.7

M&A 52

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 52

Peak Frameworks

OCTOBER 30, 2023

Loan Origination or Service Fees: This is a one-time fee charged by the bank when initiating a new loan, serving as a setup fee for the loan process. Trading and Proprietary Trading Many large banks are involved in trading activities. 2019 was a notable year for trading, especially for banks like J.P.

Bank 52

Bank Banking Proprietary Trading Investment Banking 52

Cooley M&A

JANUARY 25, 2023

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

SEPTEMBER 16, 2022

The rise of founder-led, venture capital-backed companies in recent years has coincided with a surge of companies implementing dual-class share structures in connection with their initial public offerings. Voting agreements in public M&A transactions. Stockholder litigation. As always, ambiguity begets litigation.

M&A 59

M&A IPO Shares Mergers and Acquisitions 59

Cooley M&A

JANUARY 25, 2023

The year started off with a bang, with mega-deals such as Microsoft’s pending $69 billion acquisition of Activision Blizzard, Elon Musk’s $44 billion acquisition of Twitter and Broadcom’s pending $61 billion acquisition of VMware inked in quick succession. Tech M&A in 2022 was a tale of two halves.

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Cooley M&A

JANUARY 22, 2025

billion acquisition of Alpine Immune; by contrast, there were eight US biotech acquisitions exceeding $5 billion in 2023. 2024 saw companies focusing on internal research and development, innovative partnerships, and targeted bolt-on asset acquisitions to bolster their pipelines. from 2023. [1]

M&A 64

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 64

The New York Times: Mergers, Acquisitions and Dive

APRIL 3, 2024

Michael and Gerald Shvartsman, who had originally pleaded not guilty to securities fraud charges, each pleaded guilty to one count of securities fraud.

Media 144

Media Trading Securities Initial Public Offering 144

The New York Times: Mergers, Acquisitions and Dive

JULY 3, 2023

could clear the way for a merger with Trump Media & Technology Group. Digital World’s settlement with the S.E.C.

Media 88

Media Business Mergers IT 88